argenx SE | ARGX - Operating Expenses

Stock Price
614.60
Daily Change
-2.20 -0.36%
Monthly
-13.97%
Yearly
8.78%
Q1 Forecast
598.33

argenx SE reported $914.57M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
AstraZeneca USD 12.53B 4.16B Dec/2025
Galapagos EUR 120.26M 7.43M Dec/2025
Genmab DKK 565M 38M Jun/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GRIFOLS EUR 1.71B 193M Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Qiagen NV USD 418.54M 23.25M Dec/2025
UCB EUR 2.36B 108M Dec/2024